Wash. Admin. Code § 246-101-101
(1) For the purposes of this section:
(2) The conditions identified in Table HC-1 are notifiable to public health authorities under this table and this chapter.
Table HC-1 (Conditions Notifiable by Health Care Providers and Health Care Facilities)
| Notifiable Condition (Agent) | Laboratory Confirmation Required Before Submitting Case Report | Time Frame for Notification from Identification of a Case | Who Must Be Notified | Who Must Report: Health Care Providers (Providers) or Health Care Facilities (Facilities) |
| Acquired immunodeficiency syndrome (AIDS) | Within 3 business days | DOH (for facilities) and LHJ (for providers) | Both | |
| Amebic meningitis | Immediately | LHJ | Both | |
| Anaplasmosis | Within 3 business days | LHJ | Both | |
| Anthrax (Bacillus anthracis and confirmed Bacillus cereus biovar anthracis only - Do not report all Bacillus cereus) | Yes | Immediately | LHJ | Both |
| Arboviral disease (acute disease only) including, but not limited to: Chikungunya Dengue Eastern and western equine encephalitis Japanese encephalitis La Crosse encephalitis Powassan virus infection St. Louis encephalitis West Nile virus infection Zika virus infectionSee also "Yellow fever" | Within 3 business days | LHJ | Both | |
| Asthma, occupational | Within 30 days | Washington state department of labor and industries (L&I) | Both | |
| Babesiosis | Within 3 business days | LHJ | Both | |
| Baylisascariasis | Within 24 hours | LHJ | Both | |
| Birth defects - Abdominal wall defects (inclusive of gastroschisis and omphalocele) | Within 30 days | DOH | Facilities | |
| Birth defects - Autism spectrum disorders | Within 30 days | DOH | Both | |
| Birth defects - Cerebral palsy | Within 30 days | DOH | Both | |
| Birth defects - Down syndrome | Within 30 days | DOH | Facilities | |
| Birth defects - Alcohol related birth defects | Within 30 days | DOH | Both | |
| Birth defects - Hypospadias | Within 30 days | DOH | Facilities | |
| Birth defects - Limb reductions | Within 30 days | DOH | Facilities | |
| Birth defects - Neural tube defects (inclusive of anencephaly and spina bifida) | Within 30 days | DOH | Facilities | |
| Birth defects - Oral clefts (inclusive of cleft lip with/without cleft palate) | Within 30 days | DOH | Facilities | |
| Blood lead levelRST results(See WAC 246-101-200) | Providers and facilities performing blood lead level RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
| Botulism, foodborne, infant, and wound | Immediately | LHJ | Both | |
| Brucellosis | Within 24 hours | LHJ | Both | |
| Campylobacteriosis | Within 3 business days | LHJ | Both | |
| Cancer (See chapter 246-102 WAC) | ||||
| Candida auris infection or colonization | Within 24 hours | LHJ | Both | |
| Carbapenem-resistant Enterobacteriaceae infections limited to: Klebsiella species E. coli Enterobacter species | Yes | Within 3 business days | LHJ | Both |
| Chagas disease | Within 3 business days | LHJ | Both | |
| Chancroid | Within 3 business days | LHJ | Both | |
| Chlamydia trachomatis infection | Yes | Within 3 business days | LHJ | Both |
| Cholera (Vibrio cholerae O1 or O139) | Yes | Immediately | LHJ | Both |
| Coccidioidomycosis | Within 3 business days | LHJ | Both | |
| Coronavirus infection (severe communicable) SARS-associated coronavirus MERS-associated coronavirus Novel coronavirus (COVID-19) | Yes | Immediately | LHJ | Both |
| Coronavirus infection (severe communicable) Novel coronavirus (COVID-19)RST results(See WAC 246-101-200) | Providers and facilities performing Novel coronavirus (COVID-19) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
| Cryptococcus gattii or undifferentiated Cryptococcus species (i.e., Cryptococcus not identified as C. neoformans) | Yes | Within 3 business days | LHJ | Both |
| Cryptosporidiosis | Within 3 business days | LHJ | Both | |
| Cyclosporiasis | Within 3 business days | LHJ | Both | |
| Cysticercosis | Within 3 business days | LHJ | Both | |
| Diphtheria | Immediately | LHJ | Both | |
| Domoic acid poisoning | Immediately | LHJ | Both | |
| E. coli (See "Shiga toxin-producing E. coli") | ||||
| Echinococcosis | Within 3 business days | LHJ | Both | |
| Ehrlichiosis | Within 3 business days | LHJ | Both | |
| Giardiasis | Within 3 business days | LHJ | Both | |
| Glanders (Burkholderia mallei) | Yes | Immediately | LHJ | Both |
| Gonorrhea | Within 3 business days | LHJ | Both | |
| Granuloma inguinale | Within 3 business days | LHJ | Both | |
| Gunshot wounds (nonfatal) | Within 30 days | DOH | Facilities | |
| Haemophilus influenzae (invasive disease, children under 5 years of age) | Yes | Immediately | LHJ | Both |
| Hantaviral infection | Within 24 hours | LHJ | Both | |
| Hepatitis A (acute infection) | Yes | Within 24 hours | LHJ | Both |
| Hepatitis B (acute infection) | Yes | Within 24 hours | LHJ | Both |
| Hepatitis B, report pregnancy in hepatitis B virus infected patients (including carriers) | Yes | Within 3 business days | LHJ | Both |
| Hepatitis B (chronic infection) - Initial diagnosis, and previously unreported prevalent cases | Yes | Within 3 business days | LHJ | Both |
| Hepatitis B (perinatal) - Initial diagnosis, and previously unreported cases | Yes | Within 3 business days | LHJ | Both |
| Hepatitis C (acute infection) | Yes | Within 24 hours | LHJ | Both |
| Hepatitis C (acute infection)RST results(See WAC 246-101-200) | Providers and facilities performing hepatitis C (acute infection) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
| Hepatitis C (chronic infection) | Yes | Within 3 business days | LHJ | Both |
| Hepatitis C (perinatal) - Initial diagnosis, and previously unreported cases | Yes | Within 24 hours | LHJ | Both |
| Hepatitis C (chronic infection)RST results(See WAC 246-101-200) | Providers and facilities performing hepatitis C (chronic infection) RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
| Hepatitis D (acute and chronic infection) | Yes | Within 24 hours | LHJ | Both |
| Hepatitis E (acute infection) | Yes | Within 24 hours | LHJ | Both |
| Herpes simplex, neonatal and genital (initial infection only) | Within 3 business days | LHJ | Providers | |
| Histoplasmosis | Within 3 business days | LHJ | Both | |
| Human immunodeficiency virus (HIV) infection | Within 3 business days | LHJ | Both | |
| Human immunodeficiency virus (HIV) infectionRST results(See WAC 246-101-200) | Providers and facilities performing HIV infection RST shall report as a laboratory and comply with the requirements of WAC 246-101-201 through 246-101-230. | |||
| Human prion disease | Within 3 business days | LHJ | Both | |
| Hypersensitivity pneumonitis, occupational | Within 30 days | L&I | Both | |
| Influenza, novel or unsubtypable strain | Immediately | LHJ | Both | |
| Influenza-associated death (laboratory confirmed) | Yes | Within 3 business days | LHJ | Both |
| Legionellosis | Within 24 hours | LHJ | Both | |
| Leptospirosis | Within 24 hours | LHJ | Both | |
| Listeriosis | Within 24 hours | LHJ | Both | |
| Lyme disease | Within 3 business days | LHJ | Both | |
| Lymphogranuloma venereum | Within 3 business days | LHJ | Both | |
| Malaria | Within 3 business days | LHJ | Both | |
| Measles (rubeola) - Acute disease only | Immediately | LHJ | Both | |
| Melioidosis (Burkholderia pseudomallei) | Yes | Immediately | LHJ | Both |
| Meningococcal disease, invasive | Immediately | LHJ | Both | |
| Monkeypox | Immediately | LHJ | Both | |
| Mumps, acute disease only | Within 24 hours | LHJ | Both | |
| Outbreaks and suspected outbreaks | Immediately | LHJ | Both | |
| Paralytic shellfish poisoning | Immediately | LHJ | Both | |
| Pertussis | Within 24 hours | LHJ | Both | |
| Pesticide poisoning (hospitalized, fatal, or cluster) | Immediately | DOH | Both | |
| Pesticide poisoning (all other) | Within 3 business days | DOH | Both | |
| Plague | Immediately | LHJ | Both | |
| Poliomyelitis | Immediately | LHJ | Both | |
| Pregnancy in patient with hepatitis B virus | See "Hepatitis B, report pregnancy in hepatitis B virus infected patients (including carriers)" | |||
| Psittacosis | Within 24 hours | LHJ | Both | |
| Q fever | Within 24 hours | LHJ | Both | |
| Rabies (suspect or laboratory confirmed human cases and laboratory confirmed animal cases) | Yes for animal cases | Immediately | LHJ | Both |
| Rabies, suspected human exposure (suspected human rabies exposures due to a bite from or other exposure to an animal that is suspected of being infected with rabies) | Immediately | LHJ | Both | |
| Relapsing fever (borreliosis) | Within 3 business days | LHJ | Both | |
| Rickettsia infection | Within 3 business days | LHJ | Both | |
| Rubella, acute disease only (including congenital rubella syndrome) | Immediately | LHJ | Both | |
| Salmonellosis | Within 24 hours | LHJ | Both | |
| Serious adverse reactions to immunizations | Within 3 business days | LHJ | Both | |
| Shiga toxin-producing E. coli (STEC) infections/enterohemorrhagic E. coli infections | Yes | Immediately | LHJ | Both |
| Shigellosis | Within 24 hours | LHJ | Both | |
| Silicosis | Within 30 days | L&I | Both | |
| Smallpox | Immediately | LHJ | Both | |
| Syphilis | Within 3 business days | LHJ | Both | |
| Taeniasis | Within 3 business days | LHJ | Both | |
| Tetanus | Within 3 business days | LHJ | Both | |
| Tick paralysis | Within 3 business days | LHJ | Both | |
| Trichinosis | Within 3 business days | LHJ | Both | |
| Tuberculosis disease (confirmed or highly suspicious, i.e., initiation of empiric treatment) | Within 24 hours | LHJ | Both | |
| Tularemia | Immediately | LHJ | Both | |
| Typhus | Within 3 business days | LHJ | Both | |
| Vaccinia transmission | Immediately | LHJ | Both | |
| Vancomycin-resistant Staphylococcus aureus (not to include vancomycin-intermediate) | Yes | Within 24 hours | LHJ | Both |
| Varicella-associated death | Within 3 business days | LHJ | Both | |
| Vibriosis (Vibrio species not including Vibrio cholerae O1 or O139)See Cholera (Vibrio cholerae O1 or O139) | Yes | Within 24 hours | LHJ | Both |
| Viral hemorrhagic fever | Immediately | LHJ | Both | |
| Yellow fever | Immediately | LHJ | Both | |
| Yersiniosis | Within 24 hours | LHJ | Both | |
| Unexplained critical illness or death | Within 24 hours | LHJ | Both |
[Statutory Authority: RCW 43.20.050, 70.28.032, 70.104.055, 43.70.545, and 70.24.130. WSR 21-11-040 and 22-01-175, § 246-101-101, filed 5/12/21 and 12/17/21, effective 1/1/23. Statutory Authority: RCW 43.20.050. WSR 11-02-065, § 246-101-101, filed 1/4/11, effective 2/4/11. Statutory Authority: RCW 43.20.050, 70.24.125. WSR 05-03-055, § 246-101-101, filed 1/11/05, effective 2/11/05. Statutory Authority: RCW 43.20.050, 70.24.125 and 70.28.010. WSR 00-23-120, § 246-101-101, filed 11/22/00, effective 12/23/00.]